Asia-Pacific
A fresh wave of deals highlights why investors favour IP firms and why independent outfits may soon have to rethink their strategy
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Ranjna Mehta-Dutt, who moved to Chadha & Chadha after 25 years at Remfry & Sagar, says the firm plans to expand its life sciences practice through targeted recruitment and dedicated teams for bigger clients
Law firms across the world are seemingly united in their reluctance to give juniors a chance, which shouldn’t be the case
Sponsored
Sponsored
-
Sponsored by FirstLaw PCKorean pharmaceutical patentees should be encouraged by the Supreme Court’s change of stance regarding selection inventions and crystalline form inventions, report Won Sang Lee and Hyung Eun Cho of FirstLaw P.C. -
Sponsored by Anand and AnandDhruv Anand and Udita M Patro of Anand and Anand explain the significance of a recent ruling concerning trademark protection of film titles and assess the tests used to establish the copyrightability of characters
-
Sponsored by Liu, Shen & AssociatesDanchen Cheng of Liu Shen & Associates discusses the consequences of China’s amended patent law for partial design patent applications
-
Sponsored by PurpleVine IPXiaoyan Zhou of Purplevine IP analyses the Fifth Set of Listing Standards for Medical Device Companies on STAR Market of the Shanghai Stock Exchange, which encourages companies to develop core technologies
-
Sponsored by RNA, Technology and IP AttorneysWhat should Indian business owners do to protect their trade secrets? Rachna Bakhru of RNA Technology and IP Attorneys provides a guide by piecing together the various applicable statutes and principles
-
Sponsored by AJ ParkAJ Park considers the implications of the New Zealand – EU free trade agreement for wine, cheese, and Mānuka honey
